Evaluation of Nutritional Interventions to Limit Gestational Weight Gain in Women With Class III Obesity (BMI >40)
NCT07828743
Body Weight, Body Weight Changes
Birmingham, Alabama, United States
View Trial DetailsNCT Number: NCT00433810
The goal of the LABS-1 study is to assess the short-term safety of bariatric surgery.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Sacramento Bariatric, Sacramento, California, United States
The primary objectives of this study are to assess the safety of bariatric surgery by estimating the prevalence of short term adverse outcomes in a multicenter cohort of patients undergoing bariatric surgical procedures and to determine the associations between short term adverse outcomes after bariatric surgery and both clinical/demographic patient characteristics and features of operative/perioperative care
Funds are not available to pay for the surgery for patients, only to address research questions.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Looking for future studies?
Notify MeUniversity of Pittsburgh
Other
Longitudinal Assessment of Bariatric Surgery (LABS-1)
Acronym: LABS-1
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07828743
Body Weight, Body Weight Changes
Birmingham, Alabama, United States
View Trial DetailsNCT07662538
Body Weight, Digestive System Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT01525472
Body Weight, Morbid Obesity
Colombes, France
View Trial DetailsNCT07754396
Body Weight, Cardiovascular Diseases
Athens, Greece
View Trial Details